These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12963700)

  • 1. Therapeutic strategies for metastatic colorectal cancer: simultaneous, sequential, or specific?
    Rothenberg ML; Berlin JD
    J Clin Oncol; 2003 Oct; 21(20):3716-7. PubMed ID: 12963700
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecan.
    Pazdur R
    J Gastroenterol; 2000; 35 Suppl 12():131. PubMed ID: 10779234
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
    Klautke G; Fietkau R
    Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic chemotherapy for metastatic colorectal cancer: reasons to combine.
    Calvo E
    Clin Colorectal Cancer; 2002 Nov; 2(3):170-2. PubMed ID: 12482333
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
    Allegra C; George T; Yothers G
    J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
    [No Abstract]   [Full Text] [Related]  

  • 6. Current perspectives in the treatment of metastatic colorectal cancer.
    Köhne CH; Folprecht G
    Ann Oncol; 2004; 15 Suppl 4():iv43-53. PubMed ID: 15477334
    [No Abstract]   [Full Text] [Related]  

  • 7. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine combinations in the treatment of advanced colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Nov; 1(3):146-8. PubMed ID: 12450426
    [No Abstract]   [Full Text] [Related]  

  • 9. Recommendation for irinotecan, 5-fluorouracil, and leucovorin as first-line therapy for colorectal cancer.
    Fisher MD
    Clin Colorectal Cancer; 2001 Aug; 1(2):82-4. PubMed ID: 12445364
    [No Abstract]   [Full Text] [Related]  

  • 10. [5-fluorouracil and leucovorin therapy for advanced colorectal cancer].
    Shimoyama S; Kondo K; Kataoka M
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():356-9. PubMed ID: 14574912
    [No Abstract]   [Full Text] [Related]  

  • 11. New lessons from "old" chemotherapy in colorectal cancer.
    Grothey A; Sargent DJ
    J Clin Oncol; 2008 Oct; 26(28):4532-4. PubMed ID: 18824704
    [No Abstract]   [Full Text] [Related]  

  • 12. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
    Nipp RD; Ryan DP
    Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CAIRO and FOCUS studies: which lesson is to be learned?
    Koopman M; Seymour MT; Punt CJ
    Oncologist; 2009 Feb; 14(2):192-3; author reply 194-6. PubMed ID: 19251907
    [No Abstract]   [Full Text] [Related]  

  • 14. Turning point for colorectal cancer clinical trials.
    Meropol NJ
    J Clin Oncol; 2006 Jul; 24(21):3322-4. PubMed ID: 16849744
    [No Abstract]   [Full Text] [Related]  

  • 15. New combinations in metastatic colorectal cancer: what are our expectations?
    Hurwitz H
    Oncologist; 2005 May; 10(5):320-2. PubMed ID: 15851788
    [No Abstract]   [Full Text] [Related]  

  • 16. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
    Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
    [No Abstract]   [Full Text] [Related]  

  • 17. Size matters. What can we learn from a small randomized trial?
    Saltz L
    Onkologie; 2007 Apr; 30(4):167. PubMed ID: 17469240
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential vs combination colorectal cancer therapy sparks debate.
    Fricker J
    Br J Hosp Med (Lond); 2008 Mar; 69(3):130. PubMed ID: 18422214
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomized trial comparing the addition of oxaliplatin or irinotecan to high-dose leucovorin and 5-Fluorouracil intravenous bolus every two weeks in metastatic colorectal carcinoma: Southern Italy Cooperative Oncology Group 0103.
    Comella P
    Clin Colorectal Cancer; 2003 Nov; 3(3):186-9. PubMed ID: 14706179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.